A detailed history of Agf Investments LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Agf Investments LLC holds 26,933 shares of GILD stock, worth $2.53 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
26,933
Previous 14,748 82.62%
Holding current value
$2.53 Million
Previous $912,000 82.13%
% of portfolio
0.15%
Previous 0.09%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $725,494 - $828,701
12,185 Added 82.62%
26,933 $1.66 Million
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $55,411 - $62,409
960 Added 6.96%
14,748 $912,000
Q1 2022

May 10, 2022

BUY
$57.92 - $72.58 $103,213 - $129,337
1,782 Added 14.84%
13,788 $820,000
Q4 2021

Feb 01, 2022

BUY
$64.88 - $73.64 $185,427 - $210,463
2,858 Added 31.24%
12,006 $872,000
Q3 2021

Nov 10, 2021

SELL
$67.69 - $73.03 $36,958 - $39,874
-546 Reduced 5.63%
9,148 $639,000
Q2 2021

Aug 12, 2021

SELL
$63.47 - $69.35 $53,695 - $58,670
-846 Reduced 8.03%
9,694 $668,000
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $163,800 - $186,895
-2,730 Reduced 20.57%
10,540 $681,000
Q4 2020

Feb 08, 2021

SELL
$56.65 - $64.55 $564,234 - $642,918
-9,960 Reduced 42.88%
13,270 $773,000
Q3 2020

Nov 12, 2020

SELL
$62.1 - $78.08 $118,673 - $149,210
-1,911 Reduced 7.6%
23,230 $1.47 Million
Q2 2020

Aug 11, 2020

SELL
$72.34 - $84.0 $337,032 - $391,356
-4,659 Reduced 15.63%
25,141 $1.93 Million
Q1 2020

May 08, 2020

SELL
$62.63 - $80.22 $1.05 Million - $1.34 Million
-16,700 Reduced 35.91%
29,800 $2.23 Million
Q4 2019

Feb 12, 2020

BUY
$61.62 - $67.78 $239,393 - $263,325
3,885 Added 9.12%
46,500 $3.02 Million
Q3 2019

Nov 12, 2019

SELL
$62.51 - $69.0 $25,754 - $28,428
-412 Reduced 0.96%
42,615 $2.7 Million
Q2 2019

Jul 30, 2019

BUY
$61.87 - $69.38 $152,880 - $171,437
2,471 Added 6.09%
43,027 $2.91 Million
Q1 2019

May 13, 2019

BUY
$62.53 - $70.05 $482,293 - $540,295
7,713 Added 23.48%
40,556 $2.64 Million
Q4 2018

Feb 08, 2019

BUY
$60.54 - $79.0 $18,888 - $24,648
312 Added 0.96%
32,843 $2.05 Million
Q3 2018

Nov 09, 2018

BUY
$71.28 - $78.92 $6,914 - $7,655
97 Added 0.3%
32,531 $2.51 Million
Q3 2018

Nov 07, 2018

SELL
$71.28 - $78.92 $171,285 - $189,644
-2,403 Reduced 6.9%
32,434 $2.53 Million
Q2 2018

Aug 13, 2018

BUY
$64.88 - $75.68 $1.24 Million - $1.45 Million
19,123 Added 121.69%
34,837 $2.47 Million
Q1 2018

May 04, 2018

BUY
$72.84 - $88.8 $1.14 Million - $1.39 Million
15,651 Added 24842.86%
15,714 $1.19 Million
Q3 2017

Nov 09, 2017

BUY
$72.11 - $85.47 $4,542 - $5,384
63
63 $5,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Agf Investments LLC Portfolio

Follow Agf Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments LLC with notifications on news.